Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 11/20 | 0.41 |
| ▸ | CA2 | P00918 | 11/20 | 0.41 |
| ▸ | CA9 | Q16790 | 10/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.38 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexyl Formate SCHEMBL27946361 | 0.93 | CA1 (0.37) | CA1CA2CA9CA12HCAR2 | |
| Propene SCHEMBL27946362 | 0.91 | CA1 (0.36) | CA1CA2CA9CA12HCAR2 | |
| Hexane SCHEMBL27786499 | 0.90 | CA1 (0.36) | CA1CA2CA9CA12HCAR2 | |
| Butyl Formate SCHEMBL1691794 | 0.90 | ATM (0.36) | CA1CA2CA9CA12HCAR2 | |
| Butyl Formate SCHEMBL4438325 | 0.89 | ATM (0.35) | CA1CA2HCAR2 | |
| Octane SCHEMBL7865572 | 0.86 | MEN1 (0.37) | — | |
| SCHEMBL93202 | 0.85 | TSHR (0.46) | CA1CA2CA9CA12LPAR3 | |
| SCHEMBL55804 | 0.85 | TSHR (0.46) | CA1CA2CA9CA12LPAR3 | |
| SCHEMBL77313 | 0.85 | TSHR (0.46) | CA1CA2CA9CA12LPAR3 | |
| SCHEMBL156980 | 0.85 | TSHR (0.46) | CA1CA2CA9CA12LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2117718-B1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECH CORP (US) | 2017-05-10 | — | — | EP | disclosed |
| US-8376142-B2 | Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies | CYTEC TECHNOLOGY CORP. (US) | 2013-02-19 | — | — | US | disclosed |
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | FTH1, FECH, SLC40A1 | CA1 50/4885CA2 39/4885CA9 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.